The evidence base sits with the molecules, not the platforms STEP studied semaglutide for weight management (NEJM 2021), SURMOUNT studied tirzepatide (NEJM 2022), and SURMOUNT-OSA looked at tirzepatide in obstructive sleep apnea (NEJM 2024)
The details of these guidelines are presented in the Supplementary Material, Table S1
Semaglutide A landmark study published in the New England Journal of Medicine in March 2021 involved 1,961 obese patients without type 2 diabetes
Below, we cover vial units, cost, safety checks, side effects, storage, and how compounded tirzepatide compares with the brand-name pens
The available public record does not confirm surgical intervention
Don't Wait for HR to Figure This Out You do not need HR to find this